Literature DB >> 15699502

Prevalence of diabetes-associated autoantibodies in schoolchildren: the Karlsburg Type 1 Diabetes Risk Study.

Michael Schlosser1, Martina Strebelow, Ilona Rjasanowski, Wolfgang Kerner, Ralf Wassmuth, Manfred Ziegler.   

Abstract

This study attempts to assess the prevalence of diabetes-associated autoantibodies in a general population in the northeastern part of Germany, with emphasis on autoantibodies against glutamic acid decarboxylase (GADA), protein tyrosine phosphatase (IA-2A), and insulin (IAA) by radioassays >/= 98th percentile, and AAbs binding on pancreatic sections (ICA) by immunofluorescence >/= 10 Juvenile Diabetes Foundation units. From a total of 11,840 schoolchildren tested for all four AAbs, 821 (6.9%) children were positive for single AAbs, whereas 83 (0.7%) had multiple AAbs. If the primary screening were performed by testing GADA/IA-2A/IAA, 94% of probands with single AAbs and all with multiple AAbs would be identified. The combinations of GADA/IA-2A, GADA/IAA, and IA-2A/IAA would identify 97.6, 98.8, and 85.5% of probands with multiple AAbs, respectively. Thus, combined AAb screening in the general population identifies those probands at risk for diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15699502     DOI: 10.1196/annals.1337.017

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  β-cell autoimmunity in overweight non-diabetic youth: any implications?

Authors:  Ingrid M Libman; E Barinas-Mitchell; S Marcovina; F Bacha; T Hannon; H Tfayli; S J Lee; S Bansal; R Robertson; S Arslanian
Journal:  Pediatr Diabetes       Date:  2010-09-07       Impact factor: 4.866

2.  Parameters influencing antigen-specific immunotherapy for Type 1 diabetes.

Authors:  Bo Wang; Roland Tisch
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Parameters influencing antigen-specific immunotherapy for type 1 diabetes.

Authors:  Bo Wang; Roland Tisch
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk.

Authors:  M Schlosser; K Koczwara; H Kenk; M Strebelow; I Rjasanowski; R Wassmuth; P Achenbach; A-G Ziegler; E Bonifacio
Journal:  Diabetologia       Date:  2005-07-12       Impact factor: 10.122

5.  GAD autoantibody affinity in schoolchildren from the general population.

Authors:  Christine Bender; Michael Schlosser; Urs Christen; Anette G Ziegler; Peter Achenbach
Journal:  Diabetologia       Date:  2014-06-18       Impact factor: 10.122

6.  Validation of a rapid type 1 diabetes autoantibody screening assay for community-based screening of organ donors to identify subjects at increased risk for the disease.

Authors:  C Wasserfall; E Montgomery; L Yu; A Michels; R Gianani; A Pugliese; C Nierras; J S Kaddis; D A Schatz; E Bonifacio; M A Atkinson
Journal:  Clin Exp Immunol       Date:  2016-05-04       Impact factor: 4.330

7.  GAD65 autoantibodies and glucose tolerance in offspring born to women with and without type 1 diabetes (The EPICOM study).

Authors:  Sine Knorr; Magnus C Lydolph; Birgitte Bytoft; Zuzana Lohse; Tine D Clausen; Rikke Beck Jensen; Peter Damm; Kurt Højlund; Dorte M Jensen; Claus H Gravholt
Journal:  Endocrinol Diabetes Metab       Date:  2021-11-19

8.  Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study.

Authors:  Elin Pettersen Sørgjerd; Per M Thorsby; Peter A Torjesen; Frank Skorpen; Kirsti Kvaløy; Valdemar Grill
Journal:  BMJ Open Diabetes Res Care       Date:  2015-06-25

9.  Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study.

Authors:  Jennifer Raab; Florian Haupt; Marlon Scholz; Claudia Matzke; Katharina Warncke; Karin Lange; Robin Assfalg; Katharina Weininger; Susanne Wittich; Stephanie Löbner; Andreas Beyerlein; Uta Nennstiel-Ratzel; Martin Lang; Otto Laub; Desiree Dunstheimer; Ezio Bonifacio; Peter Achenbach; Christiane Winkler; Anette-G Ziegler
Journal:  BMJ Open       Date:  2016-05-18       Impact factor: 2.692

10.  Activation of CD4+ and CD8+ T-lymphocytes by insulin and GAD in patients with type 1 or 2 diabetes mellitus.

Authors:  Borros Arneth
Journal:  Endocr Connect       Date:  2017-10-06       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.